Events Search and Views Navigation
February 2014
21st International Molecular Medicine Tri-Conference, Leaders in Precision Medicine Symposium
“Adaptive Licensing as an Enabler for Precision Medicine”Panel: Hans-Georg Eichler (EMA), Kenneth Oye (MIT), Ed Pezalla (Aetna), Mark Trusheim (MIT), & Thomas Unger (Pfizer).
Find out more »March 2014
DIA Euro Meeting 2014
“Creating an Adaptive Pathway for Medicines to Patients–Could this Be An Approach That Fulfills the Needs of All Decision-Makers? A Roundtable Discussion.”Moderator: Andrzej Rys (European Commission, Belgium); Hans-Georg Eichler (EMA); Jurgen Windeler (IQWiG, Germany); Tomas Salmonson (CHMP/EMA); Carole Longson (NICE); Chris James (Motor Neurone Disease Association, United Kingdom); Anton Hoos (GSK).
Find out more »April 2014
Global Updates on Accelerated Access to Innovative Medicines for Patients in Need
Workshop Co-hosted by EMA, IMI, EFPIA, & MIT
Find out more »May 2014
NORD Corporate Council Meeting
“Overview of NEWDIGS-Adaptive Licensing”Thomas Unger (Pfizer).
Find out more »June 2014
Global Clinical Scholars Training Program @ Harvard Medical School
“Overview of NEWDIGS & Adaptive Licensing”Gigi Hirsch (MIT).
Find out more »DIA 2014
(1) “Adaptive, Progressive or Risk-Based Licensing Models: What Approaches Could Be Considered by Mature and Emerging Markets?”Panel Moderator: Lawrence Liberti (CISR). Hans-Georg Eichler (EMA) – An Update on International Developments. (2) “How Can Studies that Inform Relative Effectiveness Best Be Incorporated into Global Drug Development Plans?” Panel Moderator: Chris Chinn (GSK). Mark Trusheim (MIT) – Overview of the NEWDIGS Janus Initiative.
Find out more »July 2014
The Next Act
What’s Needed to Make Orphan Drugs Readily Available to People with Rare DiseasesCo-hosted by NORD, LFE and NEWDIGS
Find out more »October 2014
Centre for Innovation in Regulatory Science (CIRS)
Invited case study presentation: “NEWDIGS – What they have discovered as critical elements.”Tony Hoos (Medicines 4 Patients)
Find out more »IRGC Annual Conference 2014
Improving Risk Regulation: From Crisis Response to Learning and Innovation. “Session 2.3 – Managing Uncertainty over the Life Cycle of Drug Development and Use: Enhancing Adaptability and Flexibility in Pharmaceutical Regulation.”Ken Oye (MIT), Tony Hoos (M4P), Hans-Georg Eichler (EMA).
Find out more »